Scienture Holdings, Inc. (FRA:4E4)

Germany flag Germany · Delayed Price · Currency is EUR
0.2560
-0.0100 (-3.76%)
At close: Jan 30, 2026
-92.89%
Market Cap15.54M -55.9%
Revenue (ttm)556.89K +207.9%
Net Income-17.52M
EPS-1.36
Shares Outn/a
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volumen/a
Average Volumen/a
Open0.2560
Previous Close0.2660
Day's Range0.2560 - 0.2560
52-Week Range0.2560 - 3.6400
Betan/a
RSI37.12
Earnings DateMar 26, 2026

About Scienture Holdings

Scienture Holdings, Inc. operates as pharmaceutical company that focuses on development and commercialization of products for the treatment of central nervous system and cardiovascular diseases in the United States. The company operates through Integra and Scienture segments. The Integra segment engages in the wholesale and sale of licensed pharmaceutical brand, generic, and non-drug products. The Scienture segment researches and develops branded pharmaceutical products. The company develops SCN-102, an oral liquid formulation of losartan potas... [Read more]

Industry Computer Programming, Data Processing, And Other Computer Related Services
Employees 19
Stock Exchange Frankfurt Stock Exchange
Ticker Symbol 4E4
Full Company Profile

Financial Performance

Financial numbers in USD Financial Statements